$VREX
Varex Imaging Corp Stock $vrex

$vrex Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 8-K Financial Statement

#000168162220000091 Filed on September 22, 2020

Income Statement

Concept	2018 Q3	2017 Q3	2017
Revenue	$204.8M	$215.7M	$698.1M
YoY Change	-5.05%	42.47%	12.58%
Cost Of Revenue	$145.6M	$138.0M	$444.6M
YoY Change	5.51%	56.11%	19.61%
Gross Profit	$59.20M	$77.70M	$253.5M
YoY Change	-23.81%	23.33%	2.05%
Gross Profit Margin	28.91%	36.02%	36.31%
Selling, General & Admin	$32.10M	$29.20M	$102.5M
YoY Change	9.93%	41.75%	19.46%
% of Gross Profit	54.22%	37.58%	40.43%
Research & Development	$20.70M	$21.90M	$67.30M
YoY Change	-5.48%	56.43%	25.79%
% of Gross Profit	34.97%	28.19%	26.55%
Depreciation & Amortization	$13.70M	$10.60M	$16.90M
YoY Change	29.25%	158.54%	72.45%
% of Gross Profit	23.14%	13.64%	6.67%
Operating Expenses	$52.80M	$51.10M	$169.8M
YoY Change	3.33%	47.69%	21.9%
Operating Profit	$6.400M	$26.60M	$83.70M
YoY Change	-75.94%	-6.34%	-23.28%
Interest Expense	-$5.100M	-$6.500M	$12.30M
YoY Change	-21.54%	-1725.0%	547.37%
% of Operating Profit	-79.69%	-24.44%	14.7%
Other Income/Expense, Net	-$1.100M	-$1.900M	-$8.900M
YoY Change	-42.11%	46.15%	117.07%
Pretax Income	$200.0K	$18.20M	$74.80M
YoY Change	-98.9%	-32.84%	-28.76%
Income Tax	$900.0K	$3.200M	$22.80M
% Of Pretax Income	450.0%	17.58%	30.48%
Net Earnings	$0.00	$14.80M	$51.60M
YoY Change	-100.0%	-15.91%	-24.67%
Net Earnings / Revenue	0.0%	6.86%	7.39%
Basic Earnings Per Share			$1.37
Diluted Earnings Per Share	$0.00	$386.4K	$1.36
COMMON SHARES
Basic Shares Outstanding	38.01M shares	37.63M shares	37.60M shares
Diluted Shares Outstanding			38.00M shares

Balance Sheet

Concept	2018 Q3	2017 Q3	2017
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.90M	$83.30M	$83.30M
YoY Change	-37.7%	143.57%	128.22%
Cash & Equivalents	$51.90M	$83.30M	$83.30M
Short-Term Investments
Other Short-Term Assets	$17.10M	$13.90M	$13.90M
YoY Change	23.02%	531.82%	265.79%
Inventory	$235.1M	$234.5M	$234.5M
Prepaid Expenses
Receivables	$154.0M	$163.6M	$163.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$458.1M	$495.3M	$495.3M
YoY Change	-7.51%	37.62%	37.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$144.9M	$148.3M	$148.3M
YoY Change	-2.29%	36.18%	36.18%
Goodwill	$243.6M	$241.9M
YoY Change	0.7%	223.83%
Intangibles	$73.80M	$91.30M
YoY Change	-19.17%	341.06%
Long-Term Investments	$51.00M	$52.30M	$52.30M
YoY Change	-2.49%	4.81%	6.09%
Other Assets	$34.50M	$11.00M	$11.00M
YoY Change	213.64%	223.53%	23.6%
Total Long-Term Assets	$529.8M	$544.8M	$544.8M
YoY Change	-2.75%	107.54%	107.54%
TOTAL ASSETS
Total Short-Term Assets	$458.1M	$495.3M	$495.3M
Total Long-Term Assets	$529.8M	$544.8M	$544.8M
Total Assets	$987.9M	$1.040B	$1.040B
YoY Change	-5.02%	67.11%	67.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$66.30M	$58.90M	$58.90M
YoY Change	12.56%	40.57%	40.57%
Accrued Expenses	$54.60M	$62.40M	$49.20M
YoY Change	-12.5%	161.09%	107.59%
Deferred Revenue	$13.50M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$25.00M	$20.00M	$20.00M
YoY Change	25.0%
Total Short-Term Liabilities	$152.0M	$151.8M	$151.8M
YoY Change	0.13%	95.12%	95.12%
LONG-TERM LIABILITIES
Long-Term Debt	$364.8M	$463.9M	$463.9M
YoY Change	-21.36%
Other Long-Term Liabilities	$29.80M	$4.700M	$4.700M
YoY Change	534.04%	-11.32%	-11.32%
Total Long-Term Liabilities	$394.6M	$468.6M	$468.6M
YoY Change	-15.79%	8741.51%	8741.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$152.0M	$151.8M	$151.8M
Total Long-Term Liabilities	$394.6M	$468.6M	$468.6M
Total Liabilities	$548.5M	$649.9M	$661.1M
YoY Change	-15.6%	654.82%	585.79%
SHAREHOLDERS EQUITY
Retained Earnings	$58.90M	$35.10M
YoY Change	67.81%
Common Stock	$400.0K	$400.0K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$426.2M	$379.0M	$379.0M
YoY Change
Total Liabilities & Shareholders Equity	$987.9M	$1.040B	$1.040B
YoY Change	-5.02%	67.11%	67.11%

Cashflow Statement

Concept	2018 Q3	2017 Q3	2017
OPERATING ACTIVITIES
Net Income	$0.00	$14.80M	$51.60M
YoY Change	-100.0%	-15.91%	-24.67%
Depreciation, Depletion And Amortization	$13.70M	$10.60M	$16.90M
YoY Change	29.25%	158.54%	72.45%
Cash From Operating Activities	$18.50M	$14.80M	$75.20M
YoY Change	25.0%	-46.18%	1.35%
INVESTING ACTIVITIES
Capital Expenditures	-$5.100M	-$12.60M	$20.20M
YoY Change	-59.52%	147.06%	-30.1%
Acquisitions			$271.8M
YoY Change			22550.0%
Other Investing Activities	-$5.400M	$4.200M	$0.00
YoY Change	-228.57%	-423.08%	-100.0%
Cash From Investing Activities	-$10.50M	-$8.400M	-$292.0M
YoY Change	25.0%	31.25%	1251.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-8.900M	-12.60M	$263.3M
YoY Change	-29.37%	-49.8%	-815.49%
NET CHANGE
Cash From Operating Activities	18.50M	14.80M	$75.20M
Cash From Investing Activities	-10.50M	-8.400M	-$292.0M
Cash From Financing Activities	-8.900M	-12.60M	$263.3M
Net Change In Cash	-900.0K	-6.200M	$47.40M
YoY Change	-85.48%	55.0%	200.0%
FREE CASH FLOW
Cash From Operating Activities	$18.50M	$14.80M	$75.20M
Capital Expenditures	-$5.100M	-$12.60M	$20.20M
Free Cash Flow	$23.60M	$27.40M	$55.00M
YoY Change	-13.87%	-15.95%	21.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q3	dei	Amendment Flag AmendmentFlag	false
CY2020Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2020Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001681622
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38026597	shares
CY2020Q3	dei	Entity Registrant Name EntityRegistrantName	VAREX IMAGING CORPORATION
CY2020Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q3	dei	Entity File Number EntityFileNumber	001-37860
CY2020Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-3434516
CY2020Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	1678 S. Pioneer Road,
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67300000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	128100000	USD
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38371305	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38026597	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38371305	shares
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2018	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	USD
CY2019Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2018Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	100000	USD
CY2020Q3	dei	Document Type DocumentType	8-K
CY2020Q3	dei	Document Period End Date DocumentPeriodEndDate	2020-09-22
CY2020Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City,
CY2020Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2020Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84104
CY2020Q3	dei	City Area Code CityAreaCode	801
CY2020Q3	dei	Local Phone Number LocalPhoneNumber	972-5000
CY2020Q3	dei	Written Communications WrittenCommunications	false
CY2020Q3	dei	Soliciting Material SolicitingMaterial	false
CY2020Q3	dei	Pre Commencement Tender Offer PreCommencementTenderOffer	false
CY2020Q3	dei	Pre Commencement Issuer Tender Offer PreCommencementIssuerTenderOffer	false
CY2020Q3	dei	Security12b Title Security12bTitle	Common Stock
CY2020Q3	dei	Trading Symbol TradingSymbol	VREX
CY2020Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	us-gaap	Revenues Revenues	780600000	USD
CY2018	us-gaap	Revenues Revenues	773400000	USD
CY2017	us-gaap	Revenues Revenues	698100000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	523900000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	519500000	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	444600000	USD
CY2019	us-gaap	Gross Profit GrossProfit	256700000	USD
CY2018	us-gaap	Gross Profit GrossProfit	253900000	USD
CY2017	us-gaap	Gross Profit GrossProfit	253500000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78100000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	83000000.0	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	123400000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	102500000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3000000.0	USD
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	211000000.0	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	209400000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	169800000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	45700000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	44500000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	83700000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	100000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	200000	USD
CY2019	us-gaap	Interest Expense InterestExpense	21100000	USD
CY2018	us-gaap	Interest Expense InterestExpense	21700000	USD
CY2017	us-gaap	Interest Expense InterestExpense	12300000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3200000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2700000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3200000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24200000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18800000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8900000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21500000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25700000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74800000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5700000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2600000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22800000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	15800000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	28300000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	52000000.0	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	800000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	400000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	15500000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	27500000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	51600000	USD
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.37
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.36
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16500000	USD
CY2019Q3	us-gaap	Assets Assets	1038900000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38200000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37900000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37600000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38600000	shares
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144900000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	290800000	USD
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38400000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38000000.0	shares
CY2019	us-gaap	Profit Loss ProfitLoss	15800000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	28300000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	52000000.0	USD
CY2019	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-6200000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	5200000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	600000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1300000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	200000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-200000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7500000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5000000.0	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	800000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	8300000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	33300000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	52800000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	300000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	800000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	400000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8000000.0	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32500000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	52400000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29900000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51900000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	141000000.0	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	154000000.0	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	248200000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	235100000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19300000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17100000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	438400000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	458100000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142300000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	243600000	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	86300000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73800000	USD
CY2019Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	53600000	USD
CY2018Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	51000000.0	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27500000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	444900000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	426200000	USD
CY2019Q3	us-gaap	Minority Interest MinorityInterest	3300000	USD
CY2018Q3	us-gaap	Assets Assets	987900000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	58200000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	66300000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	75700000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	47500000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	30700000	USD
CY2018Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	25000000.0	USD
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10500000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13200000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	175100000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	152000000.0	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	364400000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	364800000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8200000	USD
CY2018Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	23200000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32500000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8500000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	580200000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	548500000	USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	10500000	USD
CY2018Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	11100000	USD
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	400000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	400000	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	371800000	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	357600000	USD
CY2019Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1700000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5800000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	74400000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	62400000	USD
CY2018Q3	us-gaap	Minority Interest MinorityInterest	2100000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	448200000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	428300000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1038900000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	987900000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	15800000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	28300000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	52000000.0	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	11700000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	10000000.0	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	8400000	USD
CY2019	us-gaap	Depreciation Depreciation	23500000	USD
CY2018	us-gaap	Depreciation Depreciation	26000000.0	USD
CY2017	us-gaap	Depreciation Depreciation	16900000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15700000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16200000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10500000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3000000.0	USD
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2019	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
CY2018	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1300000	USD
CY2017	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	3100000	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	3100000	USD
CY2017	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019	vrex	Deferred Income Tax Expense Benefit Excluding Portionto Apic DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC	-12900000	USD
CY2018	vrex	Deferred Income Tax Expense Benefit Excluding Portionto Apic DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC	-7700000	USD
CY2017	vrex	Deferred Income Tax Expense Benefit Excluding Portionto Apic DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC	-8900000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2400000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2300000	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1800000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2300000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3900000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1300000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-800000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-700000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1800000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14800000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9000000.0	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	23100000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11100000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2400000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4200000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4300000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2000000.0	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10100000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9000000.0	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	263300000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-700000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84200000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	19900000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-500000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	19300000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	900000	USD
CY2018	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3300000	USD
CY2017	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-90400000	USD
CY2019	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2018	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	2400000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	500000	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	400000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11900000	USD
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2018	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1800000	USD
CY2017	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2019	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	500000	USD
CY2018	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	600000	USD
CY2017	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22100000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30800000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	47400000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53400000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84200000	USD
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36800000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31300000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53400000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5200000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4900000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10900000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10200000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	28100000	USD
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5200000	USD
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2400000	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1600000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71900000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	85300000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	75200000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19800000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20400000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20200000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	69500000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4800000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	271800000	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3900000	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2017	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93200000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25200000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-292000000.0	USD
CY2019	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
CY2018	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
CY2017	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	5000000.0	USD
CY2019	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	USD
CY2018	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	USD
CY2017	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	227100000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2100000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2300000	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1900000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	85400000	USD
CY2018	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10000000.0	USD
CY2017	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	749000000.0	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	87000000.0	USD
CY2018	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	106000000.0	USD
CY2017	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	255000000.0	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	800000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3800000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2800000	USD
CY2019	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3800000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	8200000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	9800000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	13800000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-6200000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	6000000.0	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1800000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2000000.0	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4000000.0	USD
CY2019	vrex	Receiptof Property ReceiptofProperty	0	USD
CY2018	vrex	Receiptof Property ReceiptofProperty	0	USD
CY2017	vrex	Receiptof Property ReceiptofProperty	15000000.0	USD
CY2019	vrex	Noncash Transfersto Parent NoncashTransferstoParent	0	USD
CY2018	vrex	Noncash Transfersto Parent NoncashTransferstoParent	0	USD
CY2017	vrex	Noncash Transfersto Parent NoncashTransferstoParent	1600000	USD
CY2016Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	526000000.0	USD
CY2017	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	51600000	USD
CY2017	vrex	Net Transfers From To Parent NetTransfersFromToParent	18400000	USD
CY2017	vrex	Distributionsto Parent DistributionstoParent	227100000	USD
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2800000	USD
CY2017	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1900000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6200000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	600000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-200000	USD
CY2017	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	2400000	USD
CY2017	us-gaap	Stockholders Equity Other StockholdersEquityOther	200000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	379000000.0	USD
CY2018	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	27800000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3800000	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2200000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3300000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000000.0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	5200000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	200000	USD
CY2018	vrex	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	1800000	USD
CY2018	us-gaap	Stockholders Equity Other StockholdersEquityOther	200000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	428300000	USD
CY2019Q3	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-3500000	USD
CY2019	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	15300000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	800000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2100000	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3800000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11700000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	1300000	USD
CY2019	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1400000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	448200000	USD
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impact of COVID-19</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The coronavirus (“COVID-19”) pandemic and the mitigation efforts by governments to attempt to control its spread created uncertainties and disruptions in the economic and financial markets. The extent to which COVID-19 will continue to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates and employment rates, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. During the quarter ended July 3, 2020, as a result of the economic downturn resulting from COVID-19, the Company experienced reduced demand in the </span></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the currently estimated future impacts of COVID-19 through the date of reissuance of these consolidated financial statements. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company’s consolidated financial statements in future reporting periods. These future developments are highly uncertain, and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the consolidated financial statements.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s Credit Agreement, as defined in Note 8, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Borrowings</span><span style="font-family:inherit;font-size:10pt;">, contains financial covenants, including certain leverage ratio covenants. The adverse effects of the COVID-19 pandemic on the Company’s financial condition and results of operations are expected to be more persistent and have been more severe than previously estimated. The Company now believes that reduced demand in the Company’s industrial segment and for certain higher end medical products will continue to negatively impact revenues, gross margin, and the other items used to calculate the Company’s financial covenants contained in its Credit Agreement. Based on the Company’s current forecasts, it is probable that the Company will be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the reissuance of these consolidated financial statements, including as early as the end of the Company's fiscal year end 2020. Failure to comply with the covenants, if not amended or waived, would result in an event of default under the Credit Agreement and the acceleration of the outstanding balance of the loans thereunder. If an event of default under the Credit Agreement occurs, then pursuant to cross default and/or cross acceleration clauses, substantially all of the Company’s other outstanding debt and derivative contract payables would become due, and all debt and derivative contracts could be terminated, which would have a material adverse impact to the Company’s operations and liquidity as the Company currently does not have the financial resources to satisfy such obligations if they were to become due and payable. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the reissuance of these consolidated financial statements.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is actively pursuing various options to prevent an event of default from occurring under the Credit Agreement. The Company is implementing actions to improve its financial results and other items used to calculate the financial covenants, such as accelerating the closure of its Santa Clara facility, the previously announced reduction in force, austerity programs related to outside services, and other appropriate actions. The Company is also taking actions to improve cash flow such as working capital reductions and reduced spending for property, plant and equipment, as well as pursuing potential additional fundraising to modify, supplement, or replace its Credit Agreement. While the Company has and continues to take actions to mitigate the risk of an event of default under the Credit Agreement, there is no assurance that it will be successful in doing so. The Company’s consolidated financial statements have been prepared on a going concern basis and do not reflect any adjustments that might result if the Company is unable to continue as a going concern.</span></div><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, goodwill and intangible assets, impairment on investments, and taxes on earnings. Actual results could differ from these estimates.</span></div>
CY2019	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification</span></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has reclassified </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> from selling, general and administrative expense to impairment of intangible assets for the year ended September 28, 2018, to conform to the current year's presentation. Such reclassifications had no impact on net earnings as previously reported.</span></div>
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019	us-gaap	Fiscal Period FiscalPeriod	<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September 30. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. Fiscal year 2018 was the 52-week period that ended on September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017. </span></div>
CY2019	vrex	Numberof Variable Interest Entities NumberofVariableInterestEntities	2	entity
CY2019Q3	us-gaap	Inventory Net InventoryNet	248200000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	235100000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51900000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29900000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83300000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51900000	USD
CY2018Q3	us-gaap	Restricted Cash RestrictedCash	1500000	USD
CY2019Q3	us-gaap	Restricted Cash RestrictedCash	1400000	USD
CY2017Q3	us-gaap	Restricted Cash RestrictedCash	900000	USD
CY2018Q3	us-gaap	Restricted Cash RestrictedCash	1500000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53400000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31300000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84200000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53400000	USD
CY2019Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	60200000	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	59800000	USD
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risk</span></div>Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for doubtful accounts based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier.
CY2019Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	160100000	USD
CY2018Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	149900000	USD
CY2019Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	27900000	USD
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	25400000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	341900000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	335600000	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	199600000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	190700000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142300000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144900000	USD
CY2019	us-gaap	Depreciation Depreciation	23500000	USD
CY2018	us-gaap	Depreciation Depreciation	26000000.0	USD
CY2017	us-gaap	Depreciation Depreciation	16900000	USD
CY2019	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	4500000	USD
CY2018	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	4200000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3000000.0	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7300000	USD
CY2017Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7000000.0	USD
CY2019	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	12900000	USD
CY2018	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	11600000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	12100000	USD
CY2018	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	11300000	USD
CY2019Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8100000	USD
CY2018Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7300000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1000000.0	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	600000	USD
CY2019	us-gaap	Other Restructuring Costs OtherRestructuringCosts	2800000	USD
CY2018	us-gaap	Other Restructuring Costs OtherRestructuringCosts	800000	USD
CY2019	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
CY2018	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1300000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	3100000	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	3100000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3000000.0	USD
CY2019	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	4500000	USD
CY2018	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	4200000	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	6200000	USD
CY2018	us-gaap	Severance Costs1 SeveranceCosts1	4300000	USD
CY2019	us-gaap	Business Exit Costs1 BusinessExitCosts1	300000	USD
CY2018	us-gaap	Business Exit Costs1 BusinessExitCosts1	800000	USD
CY2019	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	18900000	USD
CY2018	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	16700000	USD
CY2019Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	32100000	USD
CY2018Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	27000000.0	USD
CY2019Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	8100000	USD
CY2018Q3	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	7300000	USD
CY2019Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	10700000	USD
CY2018Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1400000	USD
CY2019Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2018Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2300000	USD
CY2019Q3	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	6900000	USD
CY2018Q3	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	0	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	8900000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9000000.0	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9500000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	75700000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	47500000	USD
CY2019Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3900000	USD
CY2018Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	3500000	USD
CY2019Q3	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	900000	USD
CY2018Q3	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	1300000	USD
CY2019Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	5500000	USD
CY2018Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	3300000	USD
CY2019Q3	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	19500000	USD
CY2018Q3	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	0	USD
CY2019Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2700000	USD
CY2018Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	400000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32500000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8500000	USD
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2300000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3900000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1300000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1000000.0	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1900000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1200000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1900000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3200000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2700000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3200000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	15500000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	27500000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	51600000	USD
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38200000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37900000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37600000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	400000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	500000	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	400000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38600000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38400000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38000000	shares
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.37
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.36
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1900000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1200000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000.0	shares
CY2019	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Loss DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLoss	1500000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	30700000	USD
CY2018Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	25000000.0	USD
CY2019Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5700000	USD
CY2018Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8200000	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	364400000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	364800000	USD
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	395100000	USD
CY2018Q3	us-gaap	Long Term Debt LongTermDebt	389800000	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	364400000	USD
CY2019Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5700000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	30700000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	30700000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	34300000	USD
CY2019Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	335800000	USD
CY2019Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	400800000	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	30700000	USD
CY2019Q3	vrex	Longterm Debt Excluding Current Maturities Gross LongtermDebtExcludingCurrentMaturitiesGross	370100000	USD
CY2019Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	395100000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	243600000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	47200000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	290800000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	137500000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	54000000.0	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	83500000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	110400000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	40600000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	69800000	USD
CY2019Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2800000	USD
CY2019Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2800000	USD
CY2018Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4000000.0	USD
CY2018Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	4000000.0	USD
CY2019Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	140300000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	54000000.0	USD
CY2019Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	86300000	USD
CY2018Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	114400000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	40600000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73800000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15700000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16200000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10500000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	4800000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3000000.0	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	17200000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	16300000	USD
CY2018	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	0	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14700000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	13700000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9100000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	12500000	USD
CY2019Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	83500000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	7500000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	5400000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4700000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1800000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	900000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	200000	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5100000	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5300000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4000000.0	USD
CY2019Q3	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	900000	USD
CY2018Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	11100000	USD
CY2017Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	11200000	USD
CY2019	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	500000	USD
CY2018	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	500000	USD
CY2019	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	500000	USD
CY2018	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	600000	USD
CY2019	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-600000	USD
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1220300	USD
CY2019Q3	us-gaap	Share Price SharePrice	28.28
CY2019	vrex	Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodGrantDateFairValue	3000000.0	USD
CY2019Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	10500000	USD
CY2018Q3	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	11100000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11700000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10000000.0	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8400000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2011000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.35
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	297000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	31.42
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	4000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	31.08
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	35000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	23.38
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2269000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.60
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M6D
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1220300	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1477000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	29.67
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M24D
CY2018	vrex	Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodGrantDateFairValue	3100000	USD
CY2017	vrex	Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Grant Date Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodGrantDateFairValue	9200000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.245
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.009
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1700000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1400000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	641000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	33.60
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	288000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	31.29
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	201000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	31.56
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	50000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	34.13
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	678000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	33.18
CY2019	vrex	Sharebased Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Grant Date Fair Value SharebasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue	9000000.0	USD
CY2018	vrex	Sharebased Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Grant Date Fair Value SharebasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue	10100000	USD
CY2017	vrex	Sharebased Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Grant Date Fair Value SharebasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue	11400000	USD
CY2019Q3	vrex	Sharebased Compensationby Sharebased Payment Award Equity Instruments Otherthan Options Shares Outstanding Market Value SharebasedCompensationbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsSharesOutstandingMarketValue	19200000	USD
CY2018Q3	vrex	Sharebased Compensationby Sharebased Payment Award Equity Instruments Otherthan Options Shares Outstanding Market Value SharebasedCompensationbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsSharesOutstandingMarketValue	18400000	USD
CY2017Q3	vrex	Sharebased Compensationby Sharebased Payment Award Equity Instruments Otherthan Options Shares Outstanding Market Value SharebasedCompensationbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsSharesOutstandingMarketValue	17800000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9200000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-2100000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.418
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.019
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	24800000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1300000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-300000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1600000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	6800000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7500000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	5300000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17300000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5100000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	31700000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-10000000.0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7000000.0	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7000000.0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1600000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	700000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1000000.0	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1400000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-900000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11600000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7700000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8900000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5700000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2600000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22800000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5900000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3700000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	55500000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	15600000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	22000000.0	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	19300000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21500000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25700000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74800000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.130
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0
CY2019Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7500000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.008
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.024
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.102
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.111
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.026
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.047
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.019
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.040
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.06
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.008
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.112
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.019
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.038
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent	-0.047
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.025
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.042
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.006
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.265
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.101
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.305
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.245
CY2019Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	5600000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4200000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3100000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	800000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	1600000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	1400000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1100000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	900000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24300000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3300000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	1000000.0	USD
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	1300000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	1900000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	1800000	USD
CY2019	vrex	Valuation Allowance Deferred Tax Asset Increase From Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount	12000000.0	USD
CY2018Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	46100000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18400000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18800000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4000000.0	USD
CY2019Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	27300000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	14400000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	19300000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	15200000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	10600000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	14300000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	3300000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	4100000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2300000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	4000000.0	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	35500000	USD
CY2018Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	37600000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	8200000	USD
CY2018Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	23200000	USD
CY2019Q3	vrex	Deferred Tax Assets Jurisdictional Amount Gross DeferredTaxAssetsJurisdictionalAmountGross	27300000	USD
CY2018Q3	vrex	Deferred Tax Assets Jurisdictional Amount Gross DeferredTaxAssetsJurisdictionalAmountGross	14400000	USD
CY2019Q3	vrex	Deferred Tax Liability Jurisdictional Amount Gross DeferredTaxLiabilityJurisdictionalAmountGross	35500000	USD
CY2018Q3	vrex	Deferred Tax Liability Jurisdictional Amount Gross DeferredTaxLiabilityJurisdictionalAmountGross	37600000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8200000	USD
CY2018Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	23200000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	100000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24300000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	4400000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	19900000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	14800000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-300000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4000000.0	USD
CY2017Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4300000	USD
CY2016Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2500000	USD
CY2018	vrex	Valuation Allowance Deferred Tax Asset Increase From Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount	0	USD
CY2017	vrex	Valuation Allowance Deferred Tax Asset Increase From Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount	0	USD
CY2019	vrex	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	2800000	USD
CY2018	vrex	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	2200000	USD
CY2017	vrex	Valuation Allowance Deferred Tax Asset Increase Amount ValuationAllowanceDeferredTaxAssetIncreaseAmount	2500000	USD
CY2019	vrex	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	0	USD
CY2018	vrex	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	2500000	USD
CY2017	vrex	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	700000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18800000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4000000.0	USD
CY2017Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4300000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	8200000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	13800000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2017Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	500000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	200000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	200000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	100000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	USD
CY2019	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	100000	USD
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019	us-gaap	Revenues Revenues	780600000	USD
CY2018	us-gaap	Revenues Revenues	773400000	USD
CY2017	us-gaap	Revenues Revenues	698100000	USD
CY2019	us-gaap	Gross Profit GrossProfit	256700000	USD
CY2018	us-gaap	Gross Profit GrossProfit	253900000	USD
CY2017	us-gaap	Gross Profit GrossProfit	253500000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	211000000.0	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	209400000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	169800000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19300000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24200000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18800000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8900000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21500000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25700000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	74800000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5700000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2600000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22800000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	15800000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	28300000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	52000000.0	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	800000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	400000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	15500000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	27500000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	51600000	USD
CY2019	us-gaap	Revenues Revenues	780600000	USD
CY2018	us-gaap	Revenues Revenues	773400000	USD
CY2017	us-gaap	Revenues Revenues	698100000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	142300000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144900000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27500000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6700000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6500000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4300000	USD
CY2019Q3	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	5500000	USD
CY2018Q3	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	3300000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-10200000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2700000	USD
CY2019	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23500000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34500000	USD
CY2018Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13500000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	54600000	USD
CY2018Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	22400000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29800000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	58900000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10500000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	75700000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8200000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32500000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	74400000	USD
CY2019	us-gaap	Revenues Revenues	780600000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	523900000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5700000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	15500000	USD
CY2018Q3	vrex	Contract With Customer Asset ContractWithCustomerAsset	24400000	USD
CY2019	vrex	Increase Decrease In Contractwith Customer Asset Costs Recovered From Product Returns IncreaseDecreaseInContractwithCustomerAssetCostsRecoveredFromProductReturns	-6400000	USD
CY2019	vrex	Increase Decrease In Contractwith Customer Asset Shipment Of Product Subject To Return IncreaseDecreaseInContractwithCustomerAssetShipmentOfProductSubjectToReturn	5700000	USD
CY2019Q3	vrex	Contract With Customer Asset ContractWithCustomerAsset	23700000	USD
CY2018Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	27100000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-7000000.0	USD
CY2019	vrex	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	6300000	USD
CY2019Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	26400000	USD
CY2019Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	265200000	USD

Files In Submission

Name	View Source	Status
0001681622-20-000091-index-headers.html	Edgar Link	pending
0001681622-20-000091-index.html	Edgar Link	pending
0001681622-20-000091.txt	Edgar Link	pending
0001681622-20-000091-xbrl.zip	Edgar Link	pending
exhibit231-auditorcons.htm	Edgar Link	pending
exhibit991-financialst.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form8-kcoverxreissued2.htm	Edgar Link	pending
form8-kcoverxreissued2_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrex-20200922.xsd	Edgar Link	pending
vrex-20200922_cal.xml	Edgar Link	unprocessable
vrex-20200922_def.xml	Edgar Link	unprocessable
vrex-20200922_lab.xml	Edgar Link	unprocessable
vrex-20200922_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VREX
Varex Imaging Corp Stock $vrex

2018 Q3 Form 8-K Financial Statement

#000168162220000091 Filed on September 22, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VREX Varex Imaging Corp Stock $vrex

2018 Q3 Form 8-K Financial Statement

#000168162220000091 Filed on September 22, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VREX
Varex Imaging Corp Stock $vrex